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Facilitation of Synaptic Transmission by EGL-30
Gqa and EGL-8 PLCb: DAG Binding to UNC-13
Is Required to Stimulate Acetylcholine Release
Therefore, in these cases the modulators regulate exo-
cytosis at a step downstream from Ca21 influx (Dittman
and Regehr, 1996; Isaacson and Hille, 1997).
Neurotransmitter released by exocytosis is drawn
from a population of vesicles that are immediately ready
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for release, termed the readily releasable pool. Recent
work suggests that the size of the readily releasable
pool is a target for neuromodulation. The readily releas-Summary
able pool is measured either by staining with the styril
dyes (e.g., FM1±43) or by analysis of the kinetics ofWe show that neurotransmitter release at Caenorhab-
ditis elegans neuromuscular junctions is facilitated by the rundown of postsynaptic responses following high-
frequency stimuli, which is assumed to reflect depletiona presynaptic pathway composed of a Gqa (EGL-30),
EGL-8 phospholipase Cb (PLCb), and the diacylglyc- of the releasable pool (Liu and Tsien, 1995; Ryan and
Smith, 1995; Rosenmund and Stevens, 1996). By eithererol- (DAG-) binding protein UNC-13. Activation of this
pathway increased release of acetylcholine at neuro- of these methods, serotonin increases the size of this
readily releasable pool of vesicles and facilitates releasemuscular junctions, whereas inactivation decreased
release. Phorbol esters stimulated acetylcholine re- at the crayfish neuromuscular junction (Wang and
Zucker, 1998). Phorbol esters also increase the size oflease, and this effect was blocked by a mutation that
eliminates phorbol ester binding to UNC-13. Expres- the readily released pool in both neurons and chromaffin
cells (Gillis et al., 1996; Stevens and Sullivan, 1998).sion of a constitutively membrane-bound form of UNC-
13 restored acetylcholine release to mutants lacking However, in other cases neuromodulators and phorbol
esters appear to regulate exocytosis at a step down-the egl-8 PLCb. Activation of this pathway with musca-
rinic agonists caused UNC-13 to accumulate in punc- stream of Ca21 influx without altering the readily releas-
able pool size (Isaacson and Hille, 1997; Yawo, 1999).tate structures in the ventral nerve cord. These results
suggest that presynaptic DAG facilitates synaptic Together, these results suggest that the processes of
synaptic vesicle exocytosis and recycling can be directlytransmission and that part of this effect is mediated
by UNC-13. regulated by neuromodulators in some manner but that
different mechanisms may be utilized at different syn-
apses.Introduction
To better define the mechanisms of neuromodulation,
we have carried out a genetic analysis of the inhibitionG protein±coupled receptors often modulate synaptic
and facilitation of neurotransmission in an in vivo sys-strength by regulating release of neurotransmitter from
tem, the Caenorhabditis elegans neuromuscular junc-nerve terminals. These neuromodulatory pathways can
tion. We previously showed that goa-1 Goa inhibits ace-either facilitate or inhibit neurotransmitter release (Nicoll
tylcholine release at these synapses by reducing theet al., 1990). In some cases, neuromodulators regulate
levels of UNC-13 at release sites (Nurrish et al., 1999).synaptic transmission via regulation of presynaptic ion
Here, we show that egl-30 Gqa and egl-8 phospholipasechannels, particularly voltage-dependent Ca21 chan-
Cb (PLCb) stimulate production of presynaptic diacyl-nels. N-type Ca21 currents are inhibited by a wide array
glycerol (DAG), which facilitates neurotransmitter re-of neuromodulators, at a wide range of synapses (Anwyl,
lease at neuromuscular synapses, and that this effect1991). Virtually all modulators that inhibit transmitter
is mediated in part by UNC-13. Since UNC-13 directlyrelease also inhibit Ca21 currents. Certain inwardly recti-
binds to the target SNARE (soluble N-ethylmaleimide-fied K1 channels (GIRKs) are also modulated by G pro-
sensitive fusion protein attachment receptors) syntaxintein±coupled receptors, but it is unclear if GIRK regulation
(Betz et al., 1997), these results suggest that DAG di-is utilized to modulate synaptic transmission (LuÈ scher et
rectly regulates synaptic vesicle exocytosis at theseal., 1997).
synapses.In other cases, neuromodulators are thought to directly
regulate some aspect of synaptic vesicle recycling.
ResultsNeurotransmitter is released from nerve terminals by
fusion of synaptic vesicle and presynaptic membranes
egl-8 Encodes a PLCb(Scheller, 1995; SuÈ dhof, 1995). The pool of releasable
Gqa typically stimulates PLCb activity (Taylor et al., 1991;synaptic vesicles is replenished by retrieving vesicle
Lee et al., 1992), and egl-30 Gqa has been shown tomembranes through endocytosis (Scheller, 1995; SuÈ dhof,
have this activity in transfected cells (Brundage et al.,1995). Several modulators not only inhibit evoked re-
1996). We examined the C. elegans genome data baselease of transmitter but also inhibit spontaneous trans-
and found four PLCb-encoding genes. The physical lo-mitter release, which is not dependent upon Ca21 influx.
cation of B0348.3 on the left arm of linkage group V (LG
V) suggested that it might correspond to the genetically* To whom correspondence should be addressed (e-mail: joshkap@
defined locus egl-8. Homozygous egl-8 mutants havesocrates.berkeley.edu).
² These authors contributed equally to this work. defects in egg laying, locomotion, and the posterior
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Figure 1. egl-8 Gene Structure and Location of egl-8 Mutations
(A) Closed numbered boxes show the position of exons in the genomic sequence, as determined by comparison with the cDNA sequence;
the 39 UTR is indicated by the open box. The positions of two point mutations are illustrated by arrows above the exon labeled with the allele
designation and the nature of the predicted substitution in the EGL-8 protein. The positions of the GFP and YFP insertions described in the
Experimental Procedures are also indicated.
(B) Predicted amino acid sequence of the EGL-8 protein derived from the insert of cDNA KP309. The missense mutation in the n2659 allele
is boxed, and the stop mutation in sa47 is indicated with an asterisked box.
(C) EGL-8 PLCb is similar to rat PLCb4. Boxes denote structural modules characteristic of PLCb family members (adapted from James and
Downes, 1997), and percentages show amino acid similarity between rat PLCb4 and EGL-8 within each domain. The functions of the different
domains are as follows (reviewed by James and Downes, 1997). The PH domain is thought to mediate binding of the enzyme to PIP2 and
anchoring to the plasma membrane. There are four EF hand domains; the role of these putative Ca21-binding sites in PLC function is unclear,
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Table 1. egl-8 Mutant Phenotypes and Transgenic Rescue
Egg Laying % Egl Locomotion Growth on Defecation
Genotype Transgene (Number of Animals) (Body Bends Min) 1 mM Aldicarb (pBoc/10 Cycles)
Wild-type None 0 (100) 19 6 4 2 10
egl-8(n2659) None 30 6 5 (90) 9 6 2 1 2.7 6 1.2
egl-8(sa47) None 84 6 11 (95) 5.7 6 1 1 1.0 6 0.8
egl-8(sa47) B0348 15 6 5 (25) 17.5 6 3 2 8.2 6 0.7
egl-8(sa47) EGL-8::YFP 90 6 10 (50) 14 6 2.8 2 9.0 6 0.8
Animals scored as egg laying defective (Egl) were bloated due to retention of eggs. Locomotion rates and growth on 1 mM aldicarb were
determined as described in the Experimental Procedures. pBoc refers to the posterior body contraction, one of three enteric muscle contractions
that constitute the defecation motor program. One wild-type defecation motor program occurs every 45±50 s and consists of sequential pBoc,
aBoc (anterior body contraction), and Exp (expulsion contraction) (Thomas, 1990). B0348 is a cosmid that contains the PLCb-encoding gene
and four other genes, and KP 309 is a minigene version of the PLCb tagged with YFP (see Experimental Procedures for details).
body contraction (pBoc) step of the defecation motor et al., 1995; Miller et al., 1996). As previously reported
(Miller et al., 1996), loss-of-function alleles of egl-30 Gqaprogram (Table 1). The egg laying defects and sluggish
made animals resistant to aldicarb (Figure 2A). Similarly,locomotion observed in egl-8 mutants (Table 1) were
we found that loss-of-function mutations in egl-8 PLCbsimilar to those reported for egl-30 Gqa reduction-of-
produced resistance to aldicarb in both acute andfunction alleles (Brundage et al., 1996), suggesting that
chronic assays, which was corrected by expression ofthese genes might act in a common pathway. We found
egl-8 PLCb transgenes (Figure 2; Table 1). Transientthat transgenes containing B0348.3 corrected the egg
expression of a constitutive, GTPase defective form oflaying, defecation, and locomotion defects observed in
egl-30 Gqa(Q209L) with a heat shock vector made wild-egl-8 mutants (Table 1). Furthermore, transient expres-
type animals acutely hypersensitive to aldicarb (Figuresion of a full-length B0348.3 cDNA (utilizing a heat shock
2C). By contrast, egl-8(sa47) mutants expressing egl-expression vector) also corrected the locomotion defect
30 Gqa(Q209L) were significantly less hypersensitive toof an egl-8 mutant (data not shown). Sequence analysis
aldicarb (though still more sensitive than wild-type ani-of genomic DNA isolated from egl-8 mutants revealed
mals) (Figure 2C), suggesting that the egl-8 PLCb maythat two alleles correspond to point mutations in exon
mediate some of the stimulatory effects of egl-30 Gqa.2 of the B0348.3 PLCb (Figure 1). The allele sa47 corre-
The residual effect of egl-30 Gqa(Q209L) in egl-8 mutantssponds to a nonsense mutation in exon 2 and is therefore
could reflect activation of other PLCb isoforms (threelikely to produce a severe reduction in gene activity.
others are predicted in the genome sequence), residualThe n2659 mutation (G45D) alters a conserved residue
activity of the egl-8(sa47) PLCb, or activation of otherin the pleckstrin homology (PH) domain, which is re-
Gqa targets. Together, these results suggest that egl-quired for binding to phosphatidylinositol bisphosphate
30 Gqa and egl-8 PLCb both regulate synaptic transmis-(PIP2). These results demonstrate that the B0348.3 PLCb
sion at neuromuscular junctions.corresponds to the egl-8 gene. These results also sug-
The effects of egl-30 Gqa and egl-8 PLCb on synapticgest that egl-8 alleles are loss-of-function mutations, as
transmission could reflect either a change in the releasethey have a recessive pattern of heredity, their pheno-
of acetylcholine by motor neurons or a change in the
types are corrected by expressing a wild-type egl-8
responsiveness of muscles to acetylcholine. To distin-
transgene, and their molecular nature is consistent with guish between these possibilities, we examined the ef-
a reduction in gene activity. fects of egl-30 Gqa and egl-8 PLCb on the respon-
siveness of animals to levamisole, a potent agonist for
Gqa and PLCb Regulate Acetylcholine the body muscle acetylcholine receptors (Fleming et al.,
Release at Neuromuscular Junctions 1997). We found that neither increased or decreased
One model for regulation of locomotion by egl-30 Gqa activity of egl-30 Gqa, or decreased activity of egl-8
and egl-8 PLCb is that these gene products modulate PLCb, altered the response to levamisole (Figure 2B).
synaptic transmission at neuromuscular junctions. To In contrast, control animals lacking a muscle nicotinic
test this possibility, we assayed synaptic release of ace- acetylcholine receptor (UNC-29) were resistant to the
tylcholine by measuring the sensitivity of animals to the paralytic effects of levamisole (Figure 2B). These results
acetylcholinesterase inhibitor aldicarb (Figure 2). Aldi- suggest that egl-30 Gqa and egl-8 PLCb do not de-
carb enhances the effects of endogenously released tectably alter the responsiveness of muscles to acetyl-
acetylcholine, which is the neuromuscular transmitter choline but rather that they regulate the release of ace-
for locomotion (Rand and Nonet, 1997). Aldicarb treat- tylcholine from the motor neurons.
ment causes hypercontraction of the body wall muscles
and paralysis in wild-type animals but not in mutants egl-30 Gqa and egl-8 PLCb Act in Motor Neurons
(e.g., synaptotagmin mutants) that are unable to release To determine where egl-30 Gqa and egl-8 PLCb act, we
examined the expression of green fluorescent proteinacetylcholine by exocytosis (Nonet et al., 1993; Nguyen
though deletion studies have demonstrated that they are essential for activity. The X and Y boxes constitute the catalytic domain. The C2
domain interfaces with the EF hand module and the catalytic domain, and may represent a lipid-binding domain. The G box is essential for
interaction with Gqa subunits. The region surrounding the conserved residue in the PH domain that is altered in the n2659 allele is shown.
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Figure 2. The Gqa/PLCb Pathway Regulates
Cholinergic Neurotransmission
Synaptic release of endogenous acetylcho-
line was measured by determining the onset
of paralysis induced by the cholinesterase in-
hibitor aldicarb. Data points show the mean 6
the SEM for several trials.
(A) Elimination of egl-8(1) activity (sa47am)
or reduction of egl-30(1) activity (ad806) de-
creased the release of endogenous acetyl-
choline, making animals resistant to the para-
lytic effects of aldicarb.
(B) Elimination of egl-8(1) activity (sa47am)
or reduction of egl-30(1) activity (ad806) did
not affect the sensitivity of these mutants to
the paralytic effects of the nicotinic acetyl-
choline agonist levamisole, which acts di-
rectly on receptors in body wall muscle. Simi-
larly, the muscarinic agonist arecoline did not
alter responsiveness to levamisole. As a posi-
tive control, the unc-29(e1072am) mutation,
which eliminates a subunit of a muscle nico-
tinic receptor (Fleming et al., 1997), did confer
resistance to levamisole.
(C) Increasing egl-30(1) activity through a
gain-of-function mutation enhanced release
of endogenous acetylcholine. A mutant egl-
30(Q209L) cDNA was transiently expressed
from a heat shock promoter. The egl-8(sa47am) mutation partially suppressed release in the egl-30(Q209L) background.
(D) Expression of an egl-8(1) cDNA specifically in ventral cord motor neurons from the acr-2 promoter restored wild-type aldicarb sensitivity
to egl-8(sa47am) mutants, whereas expression of egl-30(Q209L) from this promoter caused hypersensitivity to aldicarb.
(GFP) reporter constructs for these genes (Figure 3). A plays in the pBoc step of the defecation motor program.
The egl-30 Gqa construct was also expressed in pharyn-construct containing the egl-30 promoter and first five
exons and introns fused to GFP, and a rescuing egl-8 geal muscle cells, consistent with previous findings that
egl-30 plays an important role in pharyngeal pumpingminigene in which GFP was fused internally, were both
expressed in the ventral cord motor neurons, as well as (Brundage et al., 1996). The finding that egl-8 PLCb and
egl-30 Gqa are coexpressed in motor neurons suggestsin many other neurons. In addition, the egl-8 PLCb GFP
construct was also expressed in the posterior region of that they might function in these cells to regulate acetyl-
choline release.the intestine, perhaps consistent with the role this gene
Figure 3. egl-30 and egl-8 Expression Pat-
terns
In (A), EGL-30::GFP was expressed in pharyn-
geal muscles (PHA, arrow), as well as in many
neurons in the nerve ring (NR, arrow) and in
ventral cord motorneurons (arrowheads, [B
and C]). In adult animals, EGL-30::GFP was
expressed in 30 ventral cord motor neurons.
An EGL-8::GFP transcriptional fusion was ex-
pressed throughout the intestine (arrows,
[D]), whereas a rescuing EGL-8::YFP mini-
gene was localized to the posterior region
of the intestine (INT, arrow, [E]) as well as
expressed in many neurons in the head and
tail (arrows) and the ventral nerve cord motor
neurons (arrowheads, [E and F]). The EGL-
8::YFP transgene was expressed in all VA,
DA, VB, and DB neurons, as shown by double
labeling with acr-2::snb-1/cfp (data not shown).
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Figure 4. Locomotion Phenotypes of Mutants Described in this Study
(A) Wild-type animals move in sinusoidal waves of characteristic and uniform amplitude.
(B) egl-8 mutants exhibit reduced rates of locomotion and leave flattened sinusoidal tracks compared with wild-type animals.
(C) Expression of egl-30(Q209L) specifically in motor neurons from the acr-2 promoter results in exaggerated sinusoidal tracks.
(D) unc-13 mutants are almost completely paralyzed.
(E) Transgenic expression of UNC-13S(H173K), which should be unable to bind DAG (Betz et al., 1997), restores some locomotory ability to
unc-13 mutants.
If egl-30 Gqa and egl-8 PLCb act in the ventral cord not affected (Figure 5A). This effect of arecoline treat-
ment was likely due to increased synaptic transmissionmotor neurons, then we would expect that expressing
these genes with a motor neuron±specific promoter (de- at neuromuscular junctions, since unc-29 mutants, which
lack a muscle nicotinic acetylcholine receptor (Flemingrived from the acetylcholine receptor gene acr-2) should
restore normal locomotion to mutants lacking these pro- et al., 1997), were resistant to treatment with both areco-
line and aldicarb (Figure 5D). Arecoline-induced hyper-teins. Expression of egl-8 PLCb with the acr-2 promoter
restored normal locomotion rates (15.7 6 2 body bends sensitivity to aldicarb could not be explained by hyper-
responsiveness of body wall muscles to acetylcholine,per minute) and aldicarb responsiveness to egl-8 mu-
tants (Figure 2D). By contrast, expression of the GTPase- since arecoline did not alter responsiveness to the ace-
tylcholine agonist levamisole (Figure 2B). Taken to-defective, constitutively active mutant egl-30 Gqa(Q209L)
in motor neurons caused animals to become hypersensi- gether, these results suggest that the muscarinic agonist
arecoline stimulates acetylcholine release at neuromus-tive to aldicarb (Figure 2D), consistent with an increase
in acetylcholine release. In addition to these changes in cular junctions and that egl-30 Gqa is required for this
effect.aldicarb sensitivity, expression of these transgenes in
motor neurons altered locomotion behavior (Figure 4).
The amplitude of the sinusoidal wave of locomotion in
Phorbol Esters Stimulate Acetylcholine Releasehomozygous egl-8 PLCb mutants was reduced, whereas
Several published reports have shown that phorbol es-that found in transgenic animals expressing egl-30
ters (which directly bind to C1 domains and activateGqa(Q209L) in motor neurons was increased, compared
DAG-binding proteins) enhance release of neurotrans-with wild-type animals. These results suggest that egl-
mitter at many synapses (Malenka et al., 1986; Shapira30 Gqa and egl-8 PLCb act in motor neurons to directly
et al., 1987; Segal, 1989; Stevens and Sullivan, 1998).or indirectly regulate acetylcholine release, thereby
Since egl-8 PLCb produces DAG by hydrolyzing PIP2,modulating locomotion rate and behavior.
we wondered whether the effects of egl-30 Gqa and
egl-8 PLCb on neurotransmission were mediated by pro-
duction of DAG. To test this idea, we tested the effectsMuscarinic Agonists Activate the egl-30
Gqa Pathway of the phorbol ester phorbol-12-myristate-13-acetate
(PMA) on the aldicarb sensitivity of wild-type animals.The function of egl-30 Gqa and egl-8 PLCb in motor
neurons suggested that agonists that activate this path- We found that phorbol esters made animals hypersensi-
tive to aldicarb, whereas a biologically inactive phorbolway should stimulate acetylcholine release at neuro-
muscular junctions. Prior work suggested that egl-30 ester (4a-PMA) had no effect (Figures 5B and 5C). The
stimulatory effect of phorbol esters was saturated atGqa is required to mediate the effects of muscarinic
agonists, e.g., arecoline, on pharyngeal pumping (Brund- concentrations .0.25 mg/ml. This effect of phorbol ester
treatment was likely due to increased synaptic transmis-age et al., 1996). We found that exogenous arecoline
caused wild-type animals to become hypersensitive to sion at neuromuscular junctions, since unc-29 mutants
were resistant to treatment with both phorbol esters (2aldicarb, whereas homozygous egl-30 Gqa mutants were
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Figure 5. The egl-30 Gqa Pathway May Regulate DAG Levels and UNC-13S Activity
(A) Arecoline treatment of wild-type animals caused hypersensivity to aldicarb, whereas treatment of homozygous egl-30 Gqa mutants had
no effect.
(B) Exogenous phorbol esters (PMA, doses indicated) conferred hypersensitivity to the paralytic effects of aldicarb in wild-type animals.
(C) PMA treatment (0.25 mg/ml) of homozygous egl-8 and egl-30 mutants caused hypersensitivity to aldicarb. The inactive isomer 4a-PMA
had no effect.
(D) Neither PMA (2 mg/ml) nor arecoline altered the aldicarb sensitivity of homozygous unc-29 mutants.
(E) The dose±response relationship between PMA and aldicarb sensitivity was altered in animals expressing UNC-13S(H173K) (nuIs55). Aldicarb-
induced paralysis of homozygous unc-13 mutants expressing either wild-type UNC-13S::GFP (nuIs46) or UNC-13S(H173K)::GFP (nuIs55) were
compared either without treatment or following PMA treatment (dosing indicated). Similar results were obtained with two other integrated
transgenes containing the UNC-13S(H173K)::GFP construct (nuIs52 and nuIs58).
(F) PMA treatment (0.25 mg/ml) caused hypersensitivity to aldicarb in homozygous mutants carrying null alleles of rab-3 and snt-1.
(G) A myristoylated form of UNC-13S restored wild-type aldicarb sensitivity to egl-8 mutants; a nonmyristoylated unc-13S(1) rescuing construct
had little or no effect on egl-8 mutants.
mg/ml) and aldicarb (Figure 5D). Phorbol ester±induced and egl-8 PLCb stimulates acetylcholine release at neu-
romuscular junctions.hypersensitivity to aldicarb could not be explained by
hyperresponsiveness of body wall muscles to acetyl-
choline, since phorbol esters (2 mg/ml) did not alter re-
sponsiveness to the acetylcholine agonist levamisole DAG Binding to UNC-13S Is Required for Stimulation
of Acetylcholine Release(data not shown). Similarly, we found that treatment with
phorbol esters (0.25 mg/ml) restored aldicarb sensitivity One attractive candidate for the synaptic target of DAG
is UNC-13, a presynaptic DAG-binding protein (Maru-to homozygous egl-30 Gqa or egl-8(sa47) PLCb mutants
(Figure 5C), as would be expected if the role of these yama and Brenner, 1991; Ahmed et al., 1992; Kazanietz
et al., 1995a). Mutants that lack UNC-13 are resistantproteins is to produce DAG. These results suggest that
production of DAG in the motor neurons by egl-30 Gqa to aldicarb (Maruyama and Brenner, 1991; Miller et al.,
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1996), and mouse neurons lacking Munc13±1 are defec- case reflected the general inability of UNC-13S(H173K)::
tive for evoked release of glutamate (Augustin et al., GFP-expressing neurons to release acetylcholine.
1999). Two forms of UNC-13 are predicted by analysis If the altered phorbol responsiveness of UNC-13S
of cDNA clones: a long form (UNC-13L), containing 1815 (H173K)::GFP-expressing neurons were due to a general
amino acids, and a short form (UNC-13S), which con- defect in acetylcholine release, then you would predict
tains 1293 amino acids. UNC-13S and UNC-13L share that other exocytosis mutants would be equally resistant
a C1 domain, two C2 domains, and a domain that binds to phorbol esters. Homozygous mutants carrying null
the target SNARE syntaxin (Betz et al., 1997). In addition, mutations in either snt-1 (synaptotagmin) or rab-3
UNC-13L has a domain that binds to UNC-18 (nSec-1) (Rab-3) are resistant to aldicarb (Nonet et al., 1993,
(Sassa et al., 1999). We previously showed that expres- 1997). Nonetheless, phorbol ester treatment (0.25 mg/ml)
sion of a GFP-tagged form of UNC-13S restored normal of snt-1 or rab-3 mutants caused hypersensitivity to
locomotion rates and normal aldicarb responsiveness aldicarb that was similar to that observed in phorbol-
to homozygous unc-13(e51) mutants (Figure 5E; Nurrish treated wild-type animals (Figure 5F). Therefore, the re-
et al., 1999). Thus, UNC-13S activity is sufficient to re- duced potency of phorbol esters observed in animals
constitute synaptic transmission. expressing UNC-13S(H173K)::GFP cannot be explained
If UNC-13S were an important target of DAG at neuro- by a general failure in synaptic vesicle exocytosis. Thus,
muscular junctions, then mutations that prevent binding our results are most consistent with the idea that DAG
of DAG to UNC-13S should act like mutations that elimi- binding to UNC-13S is required for phorbol-induced
nate UNC-13 function. To test this hypothesis, we con- stimulation of acetylcholine release.
structed a mutant form of UNC-13S, H173K, in which
we altered a conserved residue in the C1 domain. Histi-
Forced Membrane Association of UNC-13Sdine 173 is conserved in all phorbol ester±binding C1
Compensates for Decreaseddomains (Hurley et al., 1997) and is required for coordi-
Production of DAGnating zinc ions (Zhang et al., 1995). A histidine-to-lysine
DAG often activates its targets by promoting their asso-substitution at this position abolished phorbol ester
ciation with membranes, and treatment with phorbolbinding to the C1 domain of Munc13±1 (Betz et al., 1998),
esters promotes membrane association of the mouseand other substitutions at this position abolished phor-
ortholog Munc13±1 (Betz et al., 1998). These resultsbol ester binding to protein kinase Cd (Kazanietz et al.,
suggested that the behavioral defects caused by de-1995b). While expression of wild-type UNC-13S::GFP in
creased production of presynaptic DAG (e.g., in egl-8homozygous unc-13 mutants appeared to fully restore
PLCb mutants) are the consequence of a failure to pro-synaptic function, expression of UNC-13S(H173K)::GFP
mote association of UNC-13 with the plasma membraneproduced an intermediate phenotype in which trans-
at nerve terminals. We tested this possibility by con-genic animals remained slightly uncoordinated and
structing a constitutively membrane-bound form ofslightly resistant to aldicarb (Figures 4 and 5E). The wild-
UNC-13S (myrUNC-13S) that contains a consensus se-type UNC-13S::GFP and UNC-13S(H173K)::GFP trans-
quence for amino-terminal myristoylation. Expressiongenes were equally well expressed (146 6 3 and 136 6
of myrUNC-13S in mutants lacking egl-8 PLCb dramati-8 arbitrary fluorescence units, respectively); therefore,
cally improved locomotion rate and aldicarb sensitivitythe effect of the C1 domain mutation cannot be attrib-
(Figure 5G). These results demonstrate that forced mem-uted to a difference in expression level. These results
brane association of UNC-13S partially compensatessuggest that DAG binding is not essential for all aspects
for the absence of egl-8 PLCb, as would be expectedof UNC-13S function but rather that DAG binding is likely
to regulate the basal activity of UNC-13S. if UNC-13S were an important target for the DAG pro-
The C1 domain mutation (H173K) in UNC-13S altered duced by the egl-8 PLCb.
the dose±response relationship between phorbol esters
and aldicarb sensitivity (Figures 5B and 5E). Treatment
egl-30 Gqa Regulates the Distribution of UNC-13Sof animals expressing wild-type UNC-13S::GFP with ei-
in the Ventral Nerve Cordther 2 or 0.25 mg/ml PMA produced equivalent increases
If egl-30 Gqa stimulates acetylcholine release by increas-in aldicarb sensitivity. By contrast, in animals expressing
ing the abundance of DAG in motor neurons, then weUNC-13S(H173K)::GFP, 0.25 mg/ml PMA had no detect-
might expect that egl-30 Gqa would regulate the subcel-able effect, and 2 mg/ml PMA had a reduced effect,
lular distribution of UNC-13S in motor neurons. Consis-compared with wild-type controls. These results demon-
tent with this idea, we previously showed that anotherstrate that transgene-encoded UNC-13S is the primary
GTP-binding protein, goa-1 Goa, inhibits acetylcholinephorbol receptor involved in facilitating synaptic trans-
release by decreasing the abundance of UNC-13S atmission following 0.25 mg/ml PMA treatment. One inter-
neuromuscular junctions (Nurrish et al., 1999). Thesepretation of these results is that a second, unidentified
results suggested that if egl-30 Gqa produces a locallow-affinity phorbol target accounts for the response to
change in DAG levels at neuromuscular junctions, thishigh doses (2 mg/ml) of phorbol esters. Interestingly,
could be visualized by observing a change in the distri-expression of UNC-13S(H173K)::GFP reduced but did
bution of UNC-13S in the ventral nerve cord followingnot eliminate the hypersensitivity to aldicarb caused by
activation of egl-30 Gqa.expression of egl-30 Gqa (Q209L) (data not shown). This
We tested this idea by comparing the distribution ofresult is also consistent with the idea that UNC-13S is
UNC-13S::GFP in the ventral nerve cords of untreatednot the only target responsible for egl-30 Gqa±mediated
and arecoline-treated animals (Figure 6; Table 2). As westimulation of acetylcholine release. However, it re-
mained possible that phorbol ester resistance in this previously showed (Nurrish et al., 1999), in untreated
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Figure 6. The egl-30 Gqa Pathway Regulates
the Distribution of UNC-13S::GFP in the Ven-
tral Nerve Cord
UNC-13S::GFP (expressed from the internal
unc-13S promoter nuIs46) was diffusely dis-
tributed in the ventral nerve cord axons of
untreated wild-type animals (A) but became
more punctate in the ventral cords of animals
treated with arecoline (B). This effect was not
seen in transgenic animals (nuIs52) express-
ing UNC-13S(H173K)::GFP (C) or in homozy-
gous egl-30 Gqa mutants (D). Digital images
were converted from gray scale into a 32
color look-up table (top right, NIH Image) to
visualize pixel intensities. Puncta are indi-
cated by arrowheads. Scale bar, 10 mm (A±D).
wild-type animals, UNC-13S::GFP was found in a primar- Gqa or egl-8 PLCb, suggesting that production of pre-
synaptic DAG is the limiting factor mediating facilitationily diffuse staining pattern in both the cell bodies and in
the axons of the ventral nerve cord, with a few punctate of release. Finally, we show that this facilitation of acetyl-
choline release is mediated in part by the presynapticstructures in the axons. We observed a 40% increase
(p 5 0.00003) in the number of UNC-13S::GFP punctate DAG-binding protein UNC-13. Since UNC-13 directly
binds to syntaxin (Betz et al., 1997), these results sug-structures in the ventral nerve cords of arecoline-treated
wild-type animals. This effect was not seen in arecoline- gest that DAG facilitates neurotransmitter release by
directly promoting synaptic vesicle exocytosis (at leasttreated egl-30 Gqa mutants or in arecoline-treated ani-
mals expressing UNC-13S(H173K)::GFP. These results at this particular synapse).
Acetylcholine release in our system was measured bysuggest that activation of egl-30 Gqa causes UNC-13S
to accumulate in punctate structures in the ventral nerve the responsiveness of intact animals to the acetylcholin-
esterase inhibitor aldicarb. This method has been usedcord and that this effect requires the ability of UNC-13S
to bind to DAG. extensively in the past to identify mutations that confer
aldicarb resistance (Rand and Russell, 1985; Hosono et
al., 1989; Hosono and Kamiya, 1991), many of whichDiscussion
have since been cloned and found to encode essential
components of the exocytosis machinery (Alfonso et al.,We showed that egl-30 Gqa and egl-8 PLCb act in motor
neurons to stimulate acetylcholine release (Figure 7). 1993; Nonet et al., 1993, 1997, 1998, 1999). Therefore,
it is well established that reducing acetylcholine releaseMuscarinic agonists also stimulate acetylcholine re-
lease, and this effect requires the activity of egl-30 Gqa. confers resistance to aldicarb. We show here that other
mutations (or drug treatments) cause hypersensitivity toProviding exogenous phorbol esters restores normal
acetylcholine release to mutants lacking either egl-30 aldicarb, which we interpret as an increased release of
Table 2. Quantitation of UNC-13::GFP Puncta
UNC-13S::GFP GFP Puncta/10 mm
Transgene 6SEM
Genotype and Treatment (Number of Animals)
1. Wild-type (15) WT 1.2 6 0.17
2. Wild-Type 1 arecoline (14) WT 1.8 6 0.21a
3. egl-30(ad806) Gqa (8) WT 1.3 6 0.22
4. egl-30[ad806) Gqa 1 arecoline (8) WT 1.3 6 0.25
5. Wild-type (6) H173K 1.0 6 0.2
6. Wild-type 1 arecoline (6) H173K 0.9 6 0.16
Localization of UNC-13S::GFP is controlled by arecoline and egl-30 Gaq. Numbers of UNC-13S::GFP puncta in the ventral nerve cords were
compared for the indicated strains and drug treatments, as detailed in the Experimental Procedures. Digital images were thresholded according
to pixel intensity, and puncta were counted manually. Values reported are mean 6 SE. Significance was determined by two-tailed t test.
a Significantly differs from untreated wild-type controls (p 5 0.00003) and from arecoline-treated egl-30 Gaq mutants (p 5 0.0027).
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How does DAG facilitate transmission? Facilitation
could occur by modulation of ion channels, thereby in-
creasing influx through voltage-dependent Ca21 chan-
nels and synaptic vesicle exocytosis. Phorbol esters
have been shown to activate both L- and N-type Ca21
currents and to inhibit K1 currents in neurons (O'Dell
and Alger, 1991; Parfitt and Madison, 1993; Hoffman
and Johnston, 1998). These effects are thought to occur
through activation of protein kinase C, and either could
contribute to promoting neurotransmitter release. Other
papers suggest that phorbol esters directly regulate exo-
cytosis downstream of Ca21 influx (Stevens and Sulli-
van, 1998; Wang and Zucker, 1998). Our experiments do
not address the role of DAG in regulating ion channels.
However, our results demonstrate that facilitation is in
part mediated by UNC-13S, suggesting that DAG di-
rectly regulates synaptic vesicle exocytosis or recycling.
These results are consistent with recent reports showingFigure 7. A Model for Modulation of the C. elegans Neuromuscular
that the mouse ortholog Munc13±1 acts as a presynapticJunction
phorbol receptor that facilitates synaptic transmissionWe propose that competing pathways modulate neurotransmitter
release at this synapse and that presynaptic DAG is a critical second (Betz et al., 1998; Augustin et al., 1999). Our results
messenger for both of these pathways. The egl-30 Gqa/egl-8 PLCb suggest that the mechanism by which DAG acts is by
pathway is proposed to produce DAG at motor neuron nerve termi- recruiting UNC-13S to the plasma membrane (presum-
nals, facilitating acetylcholine release. Muscarinic agonists appear ably at nerve terminals), since a constitutively mem-to couple to this pathway. The inhibitory neuromodulator serotonin
brane-bound form of UNC-13S bypasses the require-activates GOA-1, thereby decreasing DAG levels at nerve terminals
ment for egl-8 PLCb. Thus, we propose that UNC-13S(Nurrish et al., 1999). Presynaptic DAG recruits UNC-13 to the neuro-
transmitter release sites, promoting association with the nerve ter- is regulated by DAG in a manner similar to that proposed
minal membrane. Accumulation of UNC-13 at release sites could for protein kinase C (Oancea and Meyer, 1998). In addi-
provide a mechanism for DAG-mediated stimulation of synaptic tion, arecoline treatment promotes the accumulation of
transmission. Other published experiments suggest that presynap- UNC-13S in discrete punctate structures in the ventral
tic DAG also stimulates release via protein kinase C (Stevens and
nerve cord, and this effect requires both egl-30 Gqa andSullivan, 1998), and our results suggest that UNC-13 is not the only
DAG binding to UNC-13S. These punctate structuresphorbol receptor that regulates transmission at this synapse.
are likely to be acetycholine release sites, since we pre-
viously showed that inhibiting the goa-1 Goa pathwayacetylcholine. Four results support this interpretation.
promotes the accumulation of UNC-13S at release sitesFirst, the muscle nicotinic acetylcholine receptor (UNC-
(Nurrish et al., 1999). Once localized to release sites,
29) is required for paralysis induced by treatment with
UNC-13 could facilitate exocytosis through its interac-
phorbol esters and aldicarb, as would be expected if
tions with syntaxin (Betz et al., 1997). Our results suggest
phorbol esters augmented acetylcholine release. Sec-
that the interaction between UNC-13L and UNC-18
ond, increasing or decreasing the activity of egl-30 Gqa nSec-1 (Sassa et al., 1999) does not play a critical role
produces hypersensitivity and resistance to aldicarb, in synaptic transmission, as UNC-13S lacks the UNC-18
respectively. These reciprocal effects support the idea binding site, while UNC-13S expression restores normal
that hypersensitivity to aldicarb reflects increased re- aldicarb sensitivity and locomotion behavior to homozy-
lease of acetylcholine, rather than a nonspecific effect gous unc-13 mutants. However, this may be true only
of aldicarb in the hypersensitive mutants. Third, hyper- when UNC-13S is overexpressed, which is likely true
sensitivity to aldicarb does not correlate with increased here.
sensitivity of muscles to acetylcholine, since none of the How does UNC-13 regulate synaptic transmission?
conditions leading to aldicarb hypersensitivity altered We propose that UNC-13 plays two roles. UNC-13 has
sensitivity to the acetylcholine agonist levamisole. Fourth, a basal function in exocytosis, which does not depend
our site-of-action experiments demonstrate that changes upon DAG binding, as reflected by the partial activity
in aldicarb sensitivity reflect changes in the function of of UNC-13S(H173K). This basal UNC-13 activity could
ventral cord motor neurons, excluding artifactual effects reflect the activity of the long form UNC-13L or an activ-
of aldicarb on other tissues. ity of UNC-13 that is constitutively associated with nerve
How does the egl-30 Gqa pathway regulate synaptic terminals. The basal activity of UNC-13 is modulated by
transmission? Expression of egl-30 Gqa and egl-8 PLCb DAG binding. DAG binding to UNC-13 could regulate
in motor neurons is sufficient to produce changes in synaptic transmission by a variety of mechanisms. It
aldicarb sensitivity, suggesting that this pathway acts could increase the size of the readily releasable pool,
in the motor neurons. Furthermore, exogenous phorbol perhaps by playing a role in the priming of synaptic
esters compensate for the absence of this pathway, vesicles, as argued previously (Betz et al., 1998; Au-
suggesting that their physiological function is produc- gustin et al., 1999). Consistent with this idea, phorbol
tion of DAG, which in turn facilitates synaptic transmis- esters have been shown to increase the size of the
sion. These results do not exclude the possibility that readily releasable pool in both hippocampal neurons
this pathway also acts centrally, e.g., in interneurons or and chromaffin cells (Gillis et al., 1996; Stevens and
Sullivan, 1998). UNC-13 could increase the number ofsensory neurons.
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release sites. Alternatively, UNC-13 could regulate the by antagonistically regulating the levels of DAG at nerve
probability of release. Our results do not allow us to terminals.
distinguish between these possibilities. Recently, meth-
Experimental Proceduresods were described that allow direct electrophysiologi-
cal recordings to be made from C. elegans neuromuscu-
Strainslar junctions (Richmond and Jorgensen, 1999). These
Strain maintenance and genetic manipulation were performed as
methods should allow us to distinguish between these described (Brenner, 1974). Animals were cultivated at 208C, unless
possibilities. What other targets mediate facilitation by otherwise noted. The animals described as wild-type were C. ele-
DAG? Several of our results suggest that UNC-13 is not gans, variety Bristol, strain N2. The following genes and alleles were
used in this work; unless otherwise noted, alleles used are as de-the only relevant target for the egl-30 Gqa and egl-8
scribed by Wood (1988). LG I: egl-30(ad806) (Brundage et al., 1996),PLCb pathway. A form of UNC-13S that does not bind
unc-13(e51), and unc-29(e1072); LG II: rab-3(js49) (Nonet et al., 1997)DAG shifts the dose±response curve for phorbol-induced
and snt-1(md290) (Nonet et al., 1993); and LG V: egl-8(sa47)hypersensitivity to aldicarb, suggesting that neurons
(Thomas, 1990) and egl-8(n2659) (gift of E. Jorgensen, University of
contain a second low-affinity phorbol receptor that regu- Utah).
lates acetylcholine release. In addition, the UNC-13S
(H173K) mutation only partially blocks facilitation caused Isolation of egl-8 Alleles and Mutant Sequence Determination
The alleles sa47 (Thomas, 1990) and n2659 (E. Jorgensen) wereby activation of egl-30 Gqa. The simplest explanation
isolated in genetic screens for defecation-defective mutants. Thefor these results is that other DAG-binding proteins also
DNA sequence of the B0348.3 PLCb±encoding gene from theseplay a role in facilitation. Among these, a likely target is
mutants was determined by polymerase chain amplification of frag-
protein kinase C, which has been implicated in many ments containing exons and intron/exon boundaries followed by
systems in mediating facilitation of synaptic transmis- direct sequencing of these fragments in low-melting temperature
sion by phorbol esters (Stevens and Sullivan, 1998; agarose.
Yawo, 1999). The C. elegans genome data base predicts
Phenotypic Analysesseveral protein kinase C isoforms; however, mutations
Locomotion was assayed by counting body bends per minute, asare available in only one of these, the tpa-1 gene. We
described previously (SeÂ galat et al., 1995). Defecation was scoredfound that tpa-1 mutations had no effect on phorbol
by direct observation of the muscle contractions that constitute the
stimulation of aldicarb hypersensitivity (data not shown). defecation motor program (Pboc, Aboc, and Exp) in single animals
Nonetheless, other protein kinase C±encoding genes on food over a span of ten consecutive cycles. The wild-type defeca-
may be required for this phorbol response. Other poten- tion motor program consists of sequentially occurring Pboc, Aboc,
and Exp contractions every 45±50 s.tially important targets are DAG-activated Ca21 chan-
Heat shock treatments consisted of placing young adults at 338Cnels, e.g., those encoded by the transient receptor po-
for 30 min followed by a 30 min recovery period at 208C.tential (TRP) family of ion channels (Chyb et al., 1999;
Acute sensitivities to aldicarb (1 mM; Chem Services) and levami-Hofmann et al., 1999). Consistent with this idea, a puta- sole (100 mM; Sigma) were determined by assaying the time course
tive TRP channel±encoding gene (ZC21.2) is expressed of the onset of paralysis following acute exposure of a population
in the ventral cord motor neurons (Colbert et al., 1997). of animals to these drugs. In each experiment, 25±30 worms were
placed on drug plates and prodded every 10 min over a 2 hr periodFinally, it is likely that differences among synapses in
to determine if they retained the ability to move; worms that failedthe apparent mechanism for DAG-induced facilitation
to respond at all to this harsh touch were classified as paralyzed.could reflect differences in the abundance or functional
Each experiment was repeated a minimum of two times. Whereimpact of different DAG targets at different synapses.
indicated, animals were pretreated with indicated doses of PMA, 2
Thus, by changing the prevalence of various protein
mg/ml 4a-PMA, or 7.5 mM arecoline (all from Sigma) for 2 hr followed
kinase C and TRP isoforms at a synapse, the relative by treatment with 1 mM aldicarb in combination with these chemi-
impact of DAG on presynaptic ion channels or on exo- cals. In all cases, responses were scored by an experimenter un-
aware of the genotypes or drug treatments of the animals. The acutecytosis could be enhanced or diminished.
effects of aldicarb could not be measured in completely paralyzedOur results also suggest a model for the antagonism
animals, since this assay relies on the ability of animals to move.between the behavioral effects of goa-1 Goa and egl-30
Therefore, we were unable to assess the acute effects of aldicarbGqa (Figure 7). The GTP-binding proteins goa-1 Goa and on unc-13(e51), unc-64, or unc-18 mutants. Chronic sensitivity to
egl-30 Gqa regulate an overlapping set of C. elegans aldicarb was determined by placing five L4 stage hermaphrodites
behaviors, and for each of these behaviors they have on 1 mM aldicarb plates seeded with Escherichia coli and assaying
antagonistic effects (Mendel et al., 1995; SeÂ galat et al., for the presence or absence of progeny 1 week later.
1995; Brundage et al., 1996; Hajdu-Cronin et al., 1999;
DNA Constructs and Germline TransformationNurrish et al., 1999). For example, goa-1 Goa inhibits
Plasmids were constructed by standard techniques, and sequenceslocomotion, whereas egl-30 Gqa stimulates locomotion.
were verified when appropriate. Transgenic strains were con-Our results demonstrate that Goa and Gqa constitute structed by coinjecting each transgene with either ttx-3::gfp (O.
antagonistic neuromodulatory pathways regulating syn- Hobert) or rol-6(d) at concentrations of 50±100 mg/ml. For each type
aptic transmission at neuromuscular junctions in vivo. of array, at least three transgenic lines were obtained, and data
We previously showed that serotonin (acting through from a representative line are shown.
goa-1 Goa) inhibits release of neurotransmitter at these
egl-8 Constructs and Transgenessynapses by reducing the levels of the presynaptic DAG-
The egl-8 constructs and transgences were as follows: KP308, abinding protein UNC-13 at nerve terminals (Nurrish et
partial egl-8 cDNA clone constituting 3.2 kb of 59 sequence isolatedal., 1999). Conversely, muscarinic agonists (acting via
from the RB1 cDNA library (R. Barstead); yk32d11, a partial cDNA
egl-30 Gqa) stimulate release by increasing the abun- clone constituting 2.5 kb of 39 sequences (Y. Kohara); KP309, a full-
dance of DAG and UNC-13 at nerve terminals. Thus, length 4.7 kb egl-8 cDNA in Bluescript KS(1) constructed by fusing
competing pathways mediate facilitation and inhibition KP308 and yk32d11 at an internal XmaI site; KP311, heat shock±
promoted full-length egl-8 cDNA constructed by cloning into vectorof synaptic transmission, and these pathways intersect
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